The therapeutic market components aim at correcting a diseased condition post diagnosis. The industry branches out into anti-inflammatory therapy, liver diseases therapeutics, cancer therapeutics, biotherapeutics, pediatric healthcare, and equine healthcare. Leading the diverse segments that gain global growth is the anti-inflammatory therapy market. The progress of anti-cancer therapies is augmented owing to the rising prevalence of liver cancer, lung cancer, blood cancer, and prostate cancer. Castration-resistant prostate cancer (CRPC) therapeutics market that affects millions, for instance, has captured remarkable share in the global market at present.
The latest technology trends and discussions focus on targeted medicine, hormonal therapy, and immunotherapy. Meanwhile, the traditional NSAIDs, corticosteroids, anti-inflammatory biologics, chemotherapy, and radiotherapy sustain their growth over the same period. Small molecular targeted cancer therapy experience high rate of year-on-year growth in the current decade. The industry experts evaluate the difference in patient outcomes with the use of different drug delivery techniques such as oral and injectable.